CA2004293C - Diagnostic apnea monitor system - Google Patents
Diagnostic apnea monitor systemInfo
- Publication number
- CA2004293C CA2004293C CA002004293A CA2004293A CA2004293C CA 2004293 C CA2004293 C CA 2004293C CA 002004293 A CA002004293 A CA 002004293A CA 2004293 A CA2004293 A CA 2004293A CA 2004293 C CA2004293 C CA 2004293C
- Authority
- CA
- Canada
- Prior art keywords
- patient
- heart rate
- respiration
- snoring
- time intervals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
- A61B5/4818—Sleep apnoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0803—Recording apparatus specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/332—Portable devices specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B7/00—Instruments for auscultation
- A61B7/003—Detecting lung or respiration noise
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/56—Devices for preventing snoring
Abstract
In a method of diagnosing obstructive sleep apnea, snoring and respiration sounds made by a patient, as well as the patient's heart rate, are recorded while the patient is sleeping. Signals indicative of snoring sounds and the time intervals therebetween are produced from the respiration sounds and recorded, and a first respiration disturbance index representing the numbers of intervals per hour between episodes of snoring is calculated. Signals indicative of the patient's heart rate are likewise produced and recorded, and the average heart rate is calculated. A second respiration disturbance index representing the number of episodes per hour in which the patient's heart rate remained at 90 to 109% of its average rate is calculated. A physician can then evaluate the first and second disturbance indices to determine whether obstructive apnea is indicated.
Apparatus for practicing the method is also disclosed.
Apparatus for practicing the method is also disclosed.
Description
The invention is related to methods and apparatus for diagnosing sleep disorders. More particularly, the present invention is directed to ambulatory diagnostic apparatus and methods for use in treating sleep apnea.
A coincidence of a reduction in active changes of electrical heart and respiration potentials for a substantial length of time, followed by an increase in heart rate, is known to be an indication of sleep apnea. However, this type of record is subject to electrical potential artifacts that compromise the usefulness of these signals, as noted in U.S. Patents Nos. 4,422,458 and 4,580,575.
Also, snoring itself may be a risk factor when obstructive sleep apnea is suspected, depending on its pattern, and such devices cannot evaluate this condition. Also different types of sleep apnea, such as obstructive apnea and centrally caused apnea, are amenable to different therapeutic measures. These devices cannot provide the differential diagnosis needed for treatment of an apnea patient's problem.
The use of acoustic screening of res-piration by a behavior modification device that detects loud snoring, or an alarm device that wakes the patient when a period of silence occurs that indicates a dangerously long acute sleep apnea episode, is disclosed in U.S. Patent No. 4,715,367.
Other acoustic alarm devices are disclosed in U.S.
Patents 4,306,567 and 4,129,125.
Snoring is generally known to be an indicator of obstructive apnea, as distinct from neurological, centrally-caused apnea. However, the occurrence of snoring and silence, either in combination or separately, does not provide sufficient information to provide a diagnosis that is adequate for the treatment of sleep apnea. For -1- ~L
~`j ~
. ~
_, example, some brief, non-acute sleep apnea episodes disturb sleep, and can produce symptoms such as fatigue and irritability that are cumulative and can become clinically significant. However, similar silences may be detected that are not indicative of sleep apnea -- because of the acoustic difference between thoracic and abdominal breathing.
Prompt, accurate diagnosis of sleep apnea is also important because sleep apnea is a condition that can be treated, and even corrected, if it is detected and the nature of the problem causing it is identified early enough. Also, sleep apnea episodes that are not themselves life threatening are, nonetheless, a serious risk factor for the survival of cardiac patients. Early, accurate diagnosis and prompt treatment of sleep apnea is particularly important for these high-risk apnea patients.
Thus, when sleep apnea is suspected, the patient is commonly referred to a hospital "sleep center," which can provide a complete diagnosis of the patient's condition during sleep, based on a detailed, polysomnographic record. However, polysomnographic evaluation -- which monitors thoracic air pressure, partial (P) and saturated (Sa) blood oxygen pressure, abdominal and thoracic respiration potentials, breath sounds, heart rate, and possibly other indicators as well -- must be done on an in-patient basis.
Of course, such a hospital stay is expensive. It is also disruptive of the patient's daily routine in a way that may, in itself, produce sleep disturbances. Such additional disturbances may generate misleading results, and could possibly interfere with diagnosis of the underlying cause of a patient's clinical symptoms. Furthermore, the manual 2~4293 review process required to evaluate the voluminous, detailed record thus produced is both highly technical and very time-consuming.
It has been surprisingly found that the automated report provided in accordance with the present invention has produced no false negative indications despite its much greater simplicity and compactness, when that report is evaluated by skilled medical personnel. The invention also, surprisingly, has provided a complete diagnosis for 54% of the patients tested. For the remainder, the invention permits medical personnel to limit the number of patients referred for full polysomnographic evaluation to cases where centrally-caused apnea is indicated.
Ambulatory diagnostic recording apparatus includes means for sensing cardiac potentials, means for detecting heart rate from said cardiac potentials, means for detecting respiration and snoring sounds and means for récording encoded signals representing the heart rate and the detected sounds.
A diagnostic system for diagnosing obstructive sleep apnea in accordance with the present invention includes this ambulatory diagnostic recording apparatus, means for computing first and second respiration disturbance indexes from said encoded signals, and means for formatting reports including a chart of the frequency distribution of periods of silence and periods of stable heart rate and a chart of the temporal relationship between the recorded heart rate and the occurrence of the respective detected sounds.
The present invention relates to a method of diagnosing obstructive sleep apnea in a patient, comprising the steps of:
A coincidence of a reduction in active changes of electrical heart and respiration potentials for a substantial length of time, followed by an increase in heart rate, is known to be an indication of sleep apnea. However, this type of record is subject to electrical potential artifacts that compromise the usefulness of these signals, as noted in U.S. Patents Nos. 4,422,458 and 4,580,575.
Also, snoring itself may be a risk factor when obstructive sleep apnea is suspected, depending on its pattern, and such devices cannot evaluate this condition. Also different types of sleep apnea, such as obstructive apnea and centrally caused apnea, are amenable to different therapeutic measures. These devices cannot provide the differential diagnosis needed for treatment of an apnea patient's problem.
The use of acoustic screening of res-piration by a behavior modification device that detects loud snoring, or an alarm device that wakes the patient when a period of silence occurs that indicates a dangerously long acute sleep apnea episode, is disclosed in U.S. Patent No. 4,715,367.
Other acoustic alarm devices are disclosed in U.S.
Patents 4,306,567 and 4,129,125.
Snoring is generally known to be an indicator of obstructive apnea, as distinct from neurological, centrally-caused apnea. However, the occurrence of snoring and silence, either in combination or separately, does not provide sufficient information to provide a diagnosis that is adequate for the treatment of sleep apnea. For -1- ~L
~`j ~
. ~
_, example, some brief, non-acute sleep apnea episodes disturb sleep, and can produce symptoms such as fatigue and irritability that are cumulative and can become clinically significant. However, similar silences may be detected that are not indicative of sleep apnea -- because of the acoustic difference between thoracic and abdominal breathing.
Prompt, accurate diagnosis of sleep apnea is also important because sleep apnea is a condition that can be treated, and even corrected, if it is detected and the nature of the problem causing it is identified early enough. Also, sleep apnea episodes that are not themselves life threatening are, nonetheless, a serious risk factor for the survival of cardiac patients. Early, accurate diagnosis and prompt treatment of sleep apnea is particularly important for these high-risk apnea patients.
Thus, when sleep apnea is suspected, the patient is commonly referred to a hospital "sleep center," which can provide a complete diagnosis of the patient's condition during sleep, based on a detailed, polysomnographic record. However, polysomnographic evaluation -- which monitors thoracic air pressure, partial (P) and saturated (Sa) blood oxygen pressure, abdominal and thoracic respiration potentials, breath sounds, heart rate, and possibly other indicators as well -- must be done on an in-patient basis.
Of course, such a hospital stay is expensive. It is also disruptive of the patient's daily routine in a way that may, in itself, produce sleep disturbances. Such additional disturbances may generate misleading results, and could possibly interfere with diagnosis of the underlying cause of a patient's clinical symptoms. Furthermore, the manual 2~4293 review process required to evaluate the voluminous, detailed record thus produced is both highly technical and very time-consuming.
It has been surprisingly found that the automated report provided in accordance with the present invention has produced no false negative indications despite its much greater simplicity and compactness, when that report is evaluated by skilled medical personnel. The invention also, surprisingly, has provided a complete diagnosis for 54% of the patients tested. For the remainder, the invention permits medical personnel to limit the number of patients referred for full polysomnographic evaluation to cases where centrally-caused apnea is indicated.
Ambulatory diagnostic recording apparatus includes means for sensing cardiac potentials, means for detecting heart rate from said cardiac potentials, means for detecting respiration and snoring sounds and means for récording encoded signals representing the heart rate and the detected sounds.
A diagnostic system for diagnosing obstructive sleep apnea in accordance with the present invention includes this ambulatory diagnostic recording apparatus, means for computing first and second respiration disturbance indexes from said encoded signals, and means for formatting reports including a chart of the frequency distribution of periods of silence and periods of stable heart rate and a chart of the temporal relationship between the recorded heart rate and the occurrence of the respective detected sounds.
The present invention relates to a method of diagnosing obstructive sleep apnea in a patient, comprising the steps of:
;:-detecting respiration sounds made by the patient, and the patient's heart rate, while the patient is sleeping;
producing from said respiration sounds, signals indicative of snoring episodes and the time intervals therebetween;
recording said snoring sounds and the time intervals therebetween;
calculating a first respiration disturbance index representing the number of time intervals per hour between episodes of snoring;
producing signals indicative of the patient's heart rate;
recording said heart rate, calculating the average heart rate and a second respiration disturbance index representing the number of time intervals per hour in which the patient's heart rate remained within a given deviation from its average rate, evaluating said first and second respiration disturbance indices to determine whether obstructive apnea is indicated.
The invention also relates to an apparatus for diagnosing obstructive sleep apnea in a patient, comprising means for detecting respiration sounds made by the patient while sleeping;
means for producing, from said respiration sounds, signals indicative of snoring episodes and the time intervals therebetween;
means for recording said snoring sounds and the time intervals therebetween;
means for calculating a first respiration disturbance index representing the number of time intervals per hour between episodes of snoring;
A,,, , ~ ~
means for detecting the patient's heart rate while sleeping;
means for producing signals indicative of said patient's heart rate;
means for recording said heart rate; and means for calculating the average heart rate and a second respiration disturbance index representing the number of time intervals per hour in which the patient's heart rate remains within a given deviation from its average rate.
The method of diagnosing obstructive sleep apnea in accordance with the present invention computes two respiration distress indexes, derived from encoded signals representing the patient's heart rate and the occurrence of respiration sounds made by the patient, as well as charting the frequency distribution and temporal coincidence of changes in the recorded signals.
The apparatus and method provides an inexpensive, highly-automated, ambulatory diagnostic evaluation that has proven to be effective in identifying high-risk patients.
The present invention also very accurately distinguishes those patients having symptoms that appear to be similar to the symptoms of apnea, but which have a different etiology from apnea patients.
Thus, the therapy that is appropriate for these apnea patients can be more readily identified. Moreover, because the invention provides a highly reliable positive diagnosis of obstructive sleep apnea, expensive polysomnographic evaluation can be limited to apnea patients having centrally-caused apnea that requires further testing for determining the appropriate therapy.
For many apnea patients the present invention also permits sleep apnea to be treated earlier, when apnea treatment is more likely to be effective, since their diagnosis can be established with level of confidence through this out-patient procedure, making the cost and inconvenience of an in-patient polysomnographic evaluation unnecessary.
Also, for many patients, the present invention reduces the risk of complications arising because its low-cost and diagnostic effectiveness permits treatment of the problem before a patient's clinical symptoms become severe enough to justify referring the patient to a sleep center.
Another advantage of the present invention is the simplicity of the ambulatory apparatus required for this highly-effective, automated diagnostic evaluation. The recording unit is physically not unlike familiar audio devices, and its operation requires no intervention by the patient.
The timing control for the recording session is preset by medical personnel.
Another advantage of the present invention is that all data transfer and data evaluation, charting and reporting procedures are all automated.
All actions required occur in response to prompts displayed on the screen of a standard personal computer. Furthermore only very select, specific information is recorded and reported, unlike the diagnostic methods now in use.
Another advantage of the invention is the familiar, non-invasive character of the sensors that are used for this screening. These sensors can be successfully applied and worn by adult patients without assistance. The sensors and the recording units can also be worn by the patient under street clothes, if necessary.
In the drawings which illustrate the invention, A
Fig. 1 is a perspective view of the patient screening apparatus;
Fig. 2 is a schematic diagram of the diagnostic system;
Fig. 3 is an example of a diagnostic report for a first patient;
Fig. 4 is a plot of breathing sounds and snoring over an 8 hr. 21 mins. period from 11:45 p.m.
to 8:06 a.m.;
Fig. 5 is a detailed plot of breathing and snoring from 6:45 to 7:45 a.m.;
Fig. 6A shows the average heart rate and histogram during ten minute intervals over the two hour period 12-2 a.m.;
Fig. 6B shows the heart rate distribution (time at each rate) during the two hour period;
Fig. 7 A shows the snore pause distribution (time at each length of snore pause) over four hours from 12 to 4 a.m.;
Fig. 7B shows heart rate distribution (time at each interval of constant heart rate) over the four hours.
The patient monitor, shown in Fig. 1, comprises a light-weight, battery-powered data recording unit 10 that contains 64K of random access memory. The recording unit 10 has a lanyard 12 which permits the data storage unit 10 to be suspended from the patient's shoulder. The recording unit 10 is small in size as well as light in weight -- 30 mm thick, 160 x 90 mm on its face, and weighing approximately 300 grams without batteries.
A patient data cable 14 is provided, having a multi-pin connector 16 which is affixed to the recording unit 10 by two screws. The data cable 14 A
ends in a cable junction 18. A small, disc-shaped electret microphone 20 and three EKG electrodes 22, 24, 26 are attached to the cable junction 18.
The patient monitor also includes a polypropylene band 30 having a slit 32 through which the electret microphone 20 is inserted after the band 30 is fastened around the patient's neck using a hook and loop VELCRO fastener 34. The band is then adjusted so that the microphone 20 rests against the patient's larynx. The face of the microphone 20 that rests against the patient's larynx has an annular, insulative cushioning layer thereon that is covered by a disposable, annular self-adhesive cover 36. The lanyard 12 of the data recording unit 10 is attached to a shoulder holster 38 which is also insulated and cushioned to minimize patient discomfort.
Referring to Figure 2, the breath sound signal from the electret microphone is provided to two threshold detectors 60, 62. The first detector 60 determines whether the acoustic signal from the electret microphone 20 reaches a level that corresponds to the patient's normal breathing sound.
The signal from the electret microphone is also supplied to a second threshold detector 62 through a filter 64 that provides 12dB per octave signal attenuation above 800 Hz. The second threshold detector determines when this filtered signal reaches a level that corresponds to the patient's snoring sounds.
The EKG potential signal is detected differentially by two active electrodes 22 and 24, relative to the potential of a reference electrode 26, in accordance with standard clinical practice.
The EKG signal is then supplied to a peak-detector circuit 66 that measures the peak-to-peak interval - i ;:~
200~ 293 between R-wave potentials in the EKG signal. The value of the most recent interval is determined each second and encoded by a sample-and-hold circuit 68.
These samples are then recorded by the random access memory 70 as an eight-bit word for each sample. Two bits indicate the occurrence within a sample period of breath sounds and snoring, respectively, and six bits represent the value of the peak-to-peak interval in that sample period. The accuracy of the heart rate value thus encoded in a preferred embodiment of the present invention is specified as shown in Table 1.
Heart rate Resolution 150 - 20 bpm 20 bpm 21 - 30 bpm 5 bpm 31 - 130 bpm 2 bpm 131 - 160 bpm 5 bpm 161 - 200 bpm 10 bpm The recording unit 10 continuously stores these samples over an 18 hour period. The recording sessions are usually set to begin between 6 p.m. and midnight on the day when the preprogramming is done, depending on the patient's individual, customary sleep schedule.
The multi-pin connector 16 on the recording unit 10 described above is compatible with an RS232 standard, 9600 baud, computer interface and interface cable (not shown). During the follow-up session, after the recording is complete, the recording unit 10 is connected through this connector 16 to a personal computer 40 -- preferably a standard, IBM-XT
A
., .,~--or AT compatible computer -- as shown in Fig. 2.
Because, as a safety measure, the same connector 16 on the recording unit lO is used for both cables, the patient cannot be accidentally connected through the recording unit lO to the computer 40 that could transmit a dangerous electric shock to the patient.
A menu-driven data analysis and report formatting computer program is provided on a software diskette 42 which can be loaded into the micro-computer 40. The program automatically controls theadministrative procedures required to obtain a preliminary screening determination, analyzes the data provided by the recording unit lO, calculates diagnostic indexes and statistical data for the diagnostic report 46 (Figure 3) and charts 46a (Figures 4-7) and then prints them on command.
A patient who may have apnea is first put through a pre-screening procedure. The patient is weighed, measured and checked for hypertension.
Patient identification data is then entered at the computer keyboard 50 by medical personnel along with the patient's current height, weight and diastolic blood pressure, in response to prompts on the computer screen 52.
The computer program then performs a step-by-step interview routine, using either the standard apnea prescreening questionnaire formulated by the West German Society of Pneumology or an equivalent anamnesis questionnaire. The patient responds either YES or NO to question as they appear on the computer screen 52 by pressing #l or #2 on the keyboard 50, respectively. For example:
l. Has your partner noticed that your breating stops during sleeping?
( ) l-YES (positive indication) ( ) 2-NO (continue questionnaire) A
~.
. . . , ~
2. Do you find it difficult to go to sleep?
( ) l-YES (-1 point) ( ) 2-NO (0 points) 3. Do you take sleep medicines?
( ) l-YES (-1 point) ( ) 2-NO (0 points) 4. Both YES/one YES (+l point) Both NO (0 points) a. Do you often snore?
( ) l-YES
( ) 2-NO
b. When you snore, do you snore loudly and irregularly?
( ) l-YES
( ) 2-NO
producing from said respiration sounds, signals indicative of snoring episodes and the time intervals therebetween;
recording said snoring sounds and the time intervals therebetween;
calculating a first respiration disturbance index representing the number of time intervals per hour between episodes of snoring;
producing signals indicative of the patient's heart rate;
recording said heart rate, calculating the average heart rate and a second respiration disturbance index representing the number of time intervals per hour in which the patient's heart rate remained within a given deviation from its average rate, evaluating said first and second respiration disturbance indices to determine whether obstructive apnea is indicated.
The invention also relates to an apparatus for diagnosing obstructive sleep apnea in a patient, comprising means for detecting respiration sounds made by the patient while sleeping;
means for producing, from said respiration sounds, signals indicative of snoring episodes and the time intervals therebetween;
means for recording said snoring sounds and the time intervals therebetween;
means for calculating a first respiration disturbance index representing the number of time intervals per hour between episodes of snoring;
A,,, , ~ ~
means for detecting the patient's heart rate while sleeping;
means for producing signals indicative of said patient's heart rate;
means for recording said heart rate; and means for calculating the average heart rate and a second respiration disturbance index representing the number of time intervals per hour in which the patient's heart rate remains within a given deviation from its average rate.
The method of diagnosing obstructive sleep apnea in accordance with the present invention computes two respiration distress indexes, derived from encoded signals representing the patient's heart rate and the occurrence of respiration sounds made by the patient, as well as charting the frequency distribution and temporal coincidence of changes in the recorded signals.
The apparatus and method provides an inexpensive, highly-automated, ambulatory diagnostic evaluation that has proven to be effective in identifying high-risk patients.
The present invention also very accurately distinguishes those patients having symptoms that appear to be similar to the symptoms of apnea, but which have a different etiology from apnea patients.
Thus, the therapy that is appropriate for these apnea patients can be more readily identified. Moreover, because the invention provides a highly reliable positive diagnosis of obstructive sleep apnea, expensive polysomnographic evaluation can be limited to apnea patients having centrally-caused apnea that requires further testing for determining the appropriate therapy.
For many apnea patients the present invention also permits sleep apnea to be treated earlier, when apnea treatment is more likely to be effective, since their diagnosis can be established with level of confidence through this out-patient procedure, making the cost and inconvenience of an in-patient polysomnographic evaluation unnecessary.
Also, for many patients, the present invention reduces the risk of complications arising because its low-cost and diagnostic effectiveness permits treatment of the problem before a patient's clinical symptoms become severe enough to justify referring the patient to a sleep center.
Another advantage of the present invention is the simplicity of the ambulatory apparatus required for this highly-effective, automated diagnostic evaluation. The recording unit is physically not unlike familiar audio devices, and its operation requires no intervention by the patient.
The timing control for the recording session is preset by medical personnel.
Another advantage of the present invention is that all data transfer and data evaluation, charting and reporting procedures are all automated.
All actions required occur in response to prompts displayed on the screen of a standard personal computer. Furthermore only very select, specific information is recorded and reported, unlike the diagnostic methods now in use.
Another advantage of the invention is the familiar, non-invasive character of the sensors that are used for this screening. These sensors can be successfully applied and worn by adult patients without assistance. The sensors and the recording units can also be worn by the patient under street clothes, if necessary.
In the drawings which illustrate the invention, A
Fig. 1 is a perspective view of the patient screening apparatus;
Fig. 2 is a schematic diagram of the diagnostic system;
Fig. 3 is an example of a diagnostic report for a first patient;
Fig. 4 is a plot of breathing sounds and snoring over an 8 hr. 21 mins. period from 11:45 p.m.
to 8:06 a.m.;
Fig. 5 is a detailed plot of breathing and snoring from 6:45 to 7:45 a.m.;
Fig. 6A shows the average heart rate and histogram during ten minute intervals over the two hour period 12-2 a.m.;
Fig. 6B shows the heart rate distribution (time at each rate) during the two hour period;
Fig. 7 A shows the snore pause distribution (time at each length of snore pause) over four hours from 12 to 4 a.m.;
Fig. 7B shows heart rate distribution (time at each interval of constant heart rate) over the four hours.
The patient monitor, shown in Fig. 1, comprises a light-weight, battery-powered data recording unit 10 that contains 64K of random access memory. The recording unit 10 has a lanyard 12 which permits the data storage unit 10 to be suspended from the patient's shoulder. The recording unit 10 is small in size as well as light in weight -- 30 mm thick, 160 x 90 mm on its face, and weighing approximately 300 grams without batteries.
A patient data cable 14 is provided, having a multi-pin connector 16 which is affixed to the recording unit 10 by two screws. The data cable 14 A
ends in a cable junction 18. A small, disc-shaped electret microphone 20 and three EKG electrodes 22, 24, 26 are attached to the cable junction 18.
The patient monitor also includes a polypropylene band 30 having a slit 32 through which the electret microphone 20 is inserted after the band 30 is fastened around the patient's neck using a hook and loop VELCRO fastener 34. The band is then adjusted so that the microphone 20 rests against the patient's larynx. The face of the microphone 20 that rests against the patient's larynx has an annular, insulative cushioning layer thereon that is covered by a disposable, annular self-adhesive cover 36. The lanyard 12 of the data recording unit 10 is attached to a shoulder holster 38 which is also insulated and cushioned to minimize patient discomfort.
Referring to Figure 2, the breath sound signal from the electret microphone is provided to two threshold detectors 60, 62. The first detector 60 determines whether the acoustic signal from the electret microphone 20 reaches a level that corresponds to the patient's normal breathing sound.
The signal from the electret microphone is also supplied to a second threshold detector 62 through a filter 64 that provides 12dB per octave signal attenuation above 800 Hz. The second threshold detector determines when this filtered signal reaches a level that corresponds to the patient's snoring sounds.
The EKG potential signal is detected differentially by two active electrodes 22 and 24, relative to the potential of a reference electrode 26, in accordance with standard clinical practice.
The EKG signal is then supplied to a peak-detector circuit 66 that measures the peak-to-peak interval - i ;:~
200~ 293 between R-wave potentials in the EKG signal. The value of the most recent interval is determined each second and encoded by a sample-and-hold circuit 68.
These samples are then recorded by the random access memory 70 as an eight-bit word for each sample. Two bits indicate the occurrence within a sample period of breath sounds and snoring, respectively, and six bits represent the value of the peak-to-peak interval in that sample period. The accuracy of the heart rate value thus encoded in a preferred embodiment of the present invention is specified as shown in Table 1.
Heart rate Resolution 150 - 20 bpm 20 bpm 21 - 30 bpm 5 bpm 31 - 130 bpm 2 bpm 131 - 160 bpm 5 bpm 161 - 200 bpm 10 bpm The recording unit 10 continuously stores these samples over an 18 hour period. The recording sessions are usually set to begin between 6 p.m. and midnight on the day when the preprogramming is done, depending on the patient's individual, customary sleep schedule.
The multi-pin connector 16 on the recording unit 10 described above is compatible with an RS232 standard, 9600 baud, computer interface and interface cable (not shown). During the follow-up session, after the recording is complete, the recording unit 10 is connected through this connector 16 to a personal computer 40 -- preferably a standard, IBM-XT
A
., .,~--or AT compatible computer -- as shown in Fig. 2.
Because, as a safety measure, the same connector 16 on the recording unit lO is used for both cables, the patient cannot be accidentally connected through the recording unit lO to the computer 40 that could transmit a dangerous electric shock to the patient.
A menu-driven data analysis and report formatting computer program is provided on a software diskette 42 which can be loaded into the micro-computer 40. The program automatically controls theadministrative procedures required to obtain a preliminary screening determination, analyzes the data provided by the recording unit lO, calculates diagnostic indexes and statistical data for the diagnostic report 46 (Figure 3) and charts 46a (Figures 4-7) and then prints them on command.
A patient who may have apnea is first put through a pre-screening procedure. The patient is weighed, measured and checked for hypertension.
Patient identification data is then entered at the computer keyboard 50 by medical personnel along with the patient's current height, weight and diastolic blood pressure, in response to prompts on the computer screen 52.
The computer program then performs a step-by-step interview routine, using either the standard apnea prescreening questionnaire formulated by the West German Society of Pneumology or an equivalent anamnesis questionnaire. The patient responds either YES or NO to question as they appear on the computer screen 52 by pressing #l or #2 on the keyboard 50, respectively. For example:
l. Has your partner noticed that your breating stops during sleeping?
( ) l-YES (positive indication) ( ) 2-NO (continue questionnaire) A
~.
. . . , ~
2. Do you find it difficult to go to sleep?
( ) l-YES (-1 point) ( ) 2-NO (0 points) 3. Do you take sleep medicines?
( ) l-YES (-1 point) ( ) 2-NO (0 points) 4. Both YES/one YES (+l point) Both NO (0 points) a. Do you often snore?
( ) l-YES
( ) 2-NO
b. When you snore, do you snore loudly and irregularly?
( ) l-YES
( ) 2-NO
5. One to three times YES (+l point) Three times NO (0 points) a. -Are you liable to fall asleep during the day?
( ) l-YES
( ) 2-NO
b. Do you have difficulty staying awake, even when you do not want to completely relax, e.g., when reading or watching television?
( ) l-YES
( ) 2-NO
c. Do you often feel tired and exhausted?
( ) l-YES
( ) 2-NO
The patient's answers and physical condition are then scored automatically by the computer, as indicated in Table 2.
A
J~ r, Table 2 Points scored Statement -3,-2 or -1 Indication negative, findings unlikely.
50 or +1 Indication positive, findings questionable.
+2 or +3 Indication positive, findings likely.
The computer displays the statement that apnea findings are "likely" or "questionable" or "un-likely", that is automatically associated with the patient's numerical score through a lookup table in the computer program.
Recording units are only provided when the computer indicates that apnea is "likely" or "questionable", to avoid delaying other, diagnostic tests when apnea is unlikely. The recording unit is then pre-programmed before the recording session, the patient is instructed in the use of the sensor devices, and a follow-up session is scheduled for data retrieval and analysis.
The recording unit is automatically pre-programmed by attaching it to the computer 40 through an interface cable (not shown). Medical personnel select the time at which recording will begin and indicate the date and identifying number of the recording session through the keyboard 50 in response to prompts displayed on the screen 52. The computer then erases any previous data remaining in the recording unit 10 and enters a 256-character label into the memory of the recording unit 10. The label is automatically derived by the computer program from the preliminary screening data previously entered, and positively identifies both the recording session and the patient.
The patient is then instructed how to apply the microphone and EKG electrodes during this pre-programming procedure and, when the microphone and electrodes are in place, the unit's operability is tested using three LED indicator lights 54 located on the recording unit 10. One of these lights responds when the patient simulates episodes of snoring, and another responds to normal breathing sounds but stays dark when the patient stops breathing momentarily. This tests the microphone and the street amplifier, filtering and detector circuits respectively. The third responds in cadence with the patient heart beat, as reflected by the peaks of the signal provided by the EKG electrodes. Checking the rhythm of this light's response tests the sensor electrodes and the EKG amplifier peak-detector circuits.
These three lights 54 are active for 5 minutes each time the patient data cable 14 is attached to the recording unit 10. After 5 minutes the lights are automatically switched off to conserve battery power.
In the follow-up session, medical personnel retrieve the patient's preliminary screening data from the computer's memory, and format a new patient diskette 44 according to prompts supplied by the programs on the computer screen. The program`
automatically records a 256-character label on the diskette. This label is also derived from the patient's pre-screening data in the same way as the label supplied to the memory 70 of the recording unit 10 before the recording session was recorded by the computer in the recording unit during pre-pro-gramming.
~, .
_ 2004293 When the recording unit 10 is connected to the computer 40 the analysis program on the software diskette 42 first checks whether the label just recorded on the new patient diskette 44 matches the old label found in the memory of the recording unit 10. If the labels match, the program then copies the raw data provided by the recording unit 10 through the interface cable (not shown) onto the pre-formatted 360kB patient diskette 44. This procedure lasts about 90 seconds After the recorded signals have been copied, the programs then automatically calculate two respiration disturbance indexes (RDI ) from the recorded data for printing as a diagnostic report, such as the sample report shown in Fig. 3, as well as charting the raw data and statistical analysis of that data, such as those shown in Figs. 4 through 7.
The first RDI value is the number of time intervals per hour between episodes of snoring. The second RDI value is the number of time intervals per hour in which the patient's pulse rate remained at 90% to 109% of its averagé rate. That average rate is computed for each recording session. The time criterion for both RDI values limit these indexed to time intervals lasting from 11 to 60 seconds.
Intervals that are shorter or longer are not counted.
These values are reported in the section headed "Results of the long-term recording" in Fig. 3.
The computer program also reports the result of the questionnaire in the section headed "Results of the symptom evaluation" listing scores of "0" or "+1" in the categories listed in Table 3.
A
Table 3 1) Difficulty in Falling Asleep 2) Sleep Medication 3) Snoring 4) Wakefulness 5) Fitness Factors One of the fitness factors is the "Broca index" which is an obesity index derived from the relationship between the patient's weight and height.
The other fitness factor is the diastolic blood pressure. When the screening questionnaire is omitted, the computer prints out "An evaluation is not possible" in place of this symptom evaluation.
This is the case in Figure 3, however, the testing procedure was undertaken anyhow.
The charts shown in Figs. 4 through 7 are examples of charts that can be selected by the patient's physician for use in generating the diagnostic report shown in Fig. 3. All of these charts represent data monitored for a single patient during a given eight hour period. The signal tracings in Fig. 4 show the recorded data for the entire session from 11:45 p.m. to 8:06 a.m. Periods having unusual signal patterns are clearly shown as two sound detection bits on this compressed chart.
The broken line above the heart rate value "200" in each pair of traces appears when snoring is detected.
The lower bit appears when breath sounds are detected.
In Fig. 5, the period between 6:45 a.m. and 7:45 a.m. has been selected from the recording session shown in Fig. 4, for detailed study of an erratic pattern. The histograms of Figure 6A and the heart rate distribution of Figure 6B represent the period from midnight to 2 a.m. Figure 7A shows the snore pause distribution and Figure 7B shows the heart rate distribution during ten minute intervals between midnight and 4:00 a.m. This time period will be automatically selected for charting by the analysis program since it is usually a period of deep sleep for patients. Heart rate and breathing patterns during REM sleep occuring after 4 a.m., on the other hand are likely to be highly variable, due to dream activity. In deep sleep these patterns become very smooth and regular, which makes disruptions caused by apnea highly visible. Figures 4A and 4B show the histograms and heart rate distribution during ten minutes intervals over a two hour period.
The invention has been disclosed above with particular reference to a presently preferred embodiment of the invention. However, the method and apparatus in accordance with the present invention are defined by the appended claims. Those skilled in the art will recognize that modifications and variations of the disclosed embodiment can be made within the spirit and scope of the invention recited in the claims. For example, an additional parameter might be sampled and recorded to assist in achieving an adequate diagnosis of centrally-caused apnea without resorting to polysomnography.
( ) l-YES
( ) 2-NO
b. Do you have difficulty staying awake, even when you do not want to completely relax, e.g., when reading or watching television?
( ) l-YES
( ) 2-NO
c. Do you often feel tired and exhausted?
( ) l-YES
( ) 2-NO
The patient's answers and physical condition are then scored automatically by the computer, as indicated in Table 2.
A
J~ r, Table 2 Points scored Statement -3,-2 or -1 Indication negative, findings unlikely.
50 or +1 Indication positive, findings questionable.
+2 or +3 Indication positive, findings likely.
The computer displays the statement that apnea findings are "likely" or "questionable" or "un-likely", that is automatically associated with the patient's numerical score through a lookup table in the computer program.
Recording units are only provided when the computer indicates that apnea is "likely" or "questionable", to avoid delaying other, diagnostic tests when apnea is unlikely. The recording unit is then pre-programmed before the recording session, the patient is instructed in the use of the sensor devices, and a follow-up session is scheduled for data retrieval and analysis.
The recording unit is automatically pre-programmed by attaching it to the computer 40 through an interface cable (not shown). Medical personnel select the time at which recording will begin and indicate the date and identifying number of the recording session through the keyboard 50 in response to prompts displayed on the screen 52. The computer then erases any previous data remaining in the recording unit 10 and enters a 256-character label into the memory of the recording unit 10. The label is automatically derived by the computer program from the preliminary screening data previously entered, and positively identifies both the recording session and the patient.
The patient is then instructed how to apply the microphone and EKG electrodes during this pre-programming procedure and, when the microphone and electrodes are in place, the unit's operability is tested using three LED indicator lights 54 located on the recording unit 10. One of these lights responds when the patient simulates episodes of snoring, and another responds to normal breathing sounds but stays dark when the patient stops breathing momentarily. This tests the microphone and the street amplifier, filtering and detector circuits respectively. The third responds in cadence with the patient heart beat, as reflected by the peaks of the signal provided by the EKG electrodes. Checking the rhythm of this light's response tests the sensor electrodes and the EKG amplifier peak-detector circuits.
These three lights 54 are active for 5 minutes each time the patient data cable 14 is attached to the recording unit 10. After 5 minutes the lights are automatically switched off to conserve battery power.
In the follow-up session, medical personnel retrieve the patient's preliminary screening data from the computer's memory, and format a new patient diskette 44 according to prompts supplied by the programs on the computer screen. The program`
automatically records a 256-character label on the diskette. This label is also derived from the patient's pre-screening data in the same way as the label supplied to the memory 70 of the recording unit 10 before the recording session was recorded by the computer in the recording unit during pre-pro-gramming.
~, .
_ 2004293 When the recording unit 10 is connected to the computer 40 the analysis program on the software diskette 42 first checks whether the label just recorded on the new patient diskette 44 matches the old label found in the memory of the recording unit 10. If the labels match, the program then copies the raw data provided by the recording unit 10 through the interface cable (not shown) onto the pre-formatted 360kB patient diskette 44. This procedure lasts about 90 seconds After the recorded signals have been copied, the programs then automatically calculate two respiration disturbance indexes (RDI ) from the recorded data for printing as a diagnostic report, such as the sample report shown in Fig. 3, as well as charting the raw data and statistical analysis of that data, such as those shown in Figs. 4 through 7.
The first RDI value is the number of time intervals per hour between episodes of snoring. The second RDI value is the number of time intervals per hour in which the patient's pulse rate remained at 90% to 109% of its averagé rate. That average rate is computed for each recording session. The time criterion for both RDI values limit these indexed to time intervals lasting from 11 to 60 seconds.
Intervals that are shorter or longer are not counted.
These values are reported in the section headed "Results of the long-term recording" in Fig. 3.
The computer program also reports the result of the questionnaire in the section headed "Results of the symptom evaluation" listing scores of "0" or "+1" in the categories listed in Table 3.
A
Table 3 1) Difficulty in Falling Asleep 2) Sleep Medication 3) Snoring 4) Wakefulness 5) Fitness Factors One of the fitness factors is the "Broca index" which is an obesity index derived from the relationship between the patient's weight and height.
The other fitness factor is the diastolic blood pressure. When the screening questionnaire is omitted, the computer prints out "An evaluation is not possible" in place of this symptom evaluation.
This is the case in Figure 3, however, the testing procedure was undertaken anyhow.
The charts shown in Figs. 4 through 7 are examples of charts that can be selected by the patient's physician for use in generating the diagnostic report shown in Fig. 3. All of these charts represent data monitored for a single patient during a given eight hour period. The signal tracings in Fig. 4 show the recorded data for the entire session from 11:45 p.m. to 8:06 a.m. Periods having unusual signal patterns are clearly shown as two sound detection bits on this compressed chart.
The broken line above the heart rate value "200" in each pair of traces appears when snoring is detected.
The lower bit appears when breath sounds are detected.
In Fig. 5, the period between 6:45 a.m. and 7:45 a.m. has been selected from the recording session shown in Fig. 4, for detailed study of an erratic pattern. The histograms of Figure 6A and the heart rate distribution of Figure 6B represent the period from midnight to 2 a.m. Figure 7A shows the snore pause distribution and Figure 7B shows the heart rate distribution during ten minute intervals between midnight and 4:00 a.m. This time period will be automatically selected for charting by the analysis program since it is usually a period of deep sleep for patients. Heart rate and breathing patterns during REM sleep occuring after 4 a.m., on the other hand are likely to be highly variable, due to dream activity. In deep sleep these patterns become very smooth and regular, which makes disruptions caused by apnea highly visible. Figures 4A and 4B show the histograms and heart rate distribution during ten minutes intervals over a two hour period.
The invention has been disclosed above with particular reference to a presently preferred embodiment of the invention. However, the method and apparatus in accordance with the present invention are defined by the appended claims. Those skilled in the art will recognize that modifications and variations of the disclosed embodiment can be made within the spirit and scope of the invention recited in the claims. For example, an additional parameter might be sampled and recorded to assist in achieving an adequate diagnosis of centrally-caused apnea without resorting to polysomnography.
Claims (6)
1. Method of diagnosing obstructive sleep apnea in a patient, comprising the steps of:
detecting respiration sounds made by the patient, and the patient's heart rate, while the patient is sleeping;
producing from said respiration sounds, signals indicative of snoring episodes and the time intervals therebetween;
recording said snoring sounds and the time intervals therebetween;
calculating a first respiration disturbance index representing the number of time intervals per hour between episodes of snoring;
producing signals indicative of the patient's heart rate;
recording said heart rate, calculating the average heart rate and a second respiration disturbance index representing the number of time intervals per hour in which the patient's heart rate remained within a given deviation from its average rate, evaluating said first and second respiration disturbance indices to determine whether obstructive apnea is indicated.
detecting respiration sounds made by the patient, and the patient's heart rate, while the patient is sleeping;
producing from said respiration sounds, signals indicative of snoring episodes and the time intervals therebetween;
recording said snoring sounds and the time intervals therebetween;
calculating a first respiration disturbance index representing the number of time intervals per hour between episodes of snoring;
producing signals indicative of the patient's heart rate;
recording said heart rate, calculating the average heart rate and a second respiration disturbance index representing the number of time intervals per hour in which the patient's heart rate remained within a given deviation from its average rate, evaluating said first and second respiration disturbance indices to determine whether obstructive apnea is indicated.
2. Method as in claim 1 wherein the second respiration disturbance index represents the number of time intervals per hour in which the patient's heart rate remained at 90% to 109% of its average rate.
3. Method as in claim 1 wherein time intervals shorter than 11 seconds or longer than 60 seconds between episodes of snoring are not counted in calculating the first respiration disturbance index.
4. Method as in claim 1 wherein the intervals shorter than 11 seconds or longer than 60 seconds of constant heart rate are not counted in calculating the first respiration disturbance index.
5. Apparatus for diagnosing obstructive sleep apnea in a patient, comprising means for detecting respiration sounds made by the patient while sleeping;
means for producing, from said respiration sounds, signals indicative of snoring episodes and the time intervals therebetween;
means for recording said snoring sounds and the time intervals therebetween;
means for calculating a first respiration disturbance index representing the number of time intervals per hour between episodes of snoring;
means for detecting the patient's heart rate while sleeping;
means for producing signals indicative of said patient's heart rate;
means for recording said heart rate; and means for calculating the average heart rate and a second respiration disturbance index representing the number of time intervals per hour in which the patient's heart rate remains within a given deviation from its average rate.
means for producing, from said respiration sounds, signals indicative of snoring episodes and the time intervals therebetween;
means for recording said snoring sounds and the time intervals therebetween;
means for calculating a first respiration disturbance index representing the number of time intervals per hour between episodes of snoring;
means for detecting the patient's heart rate while sleeping;
means for producing signals indicative of said patient's heart rate;
means for recording said heart rate; and means for calculating the average heart rate and a second respiration disturbance index representing the number of time intervals per hour in which the patient's heart rate remains within a given deviation from its average rate.
6. Apparatus as in claim 5 wherein said means for calculating said first respiration disturbance index and said means for calculating said average heart rate and said second respiration disturbance index comprises a single computer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/278,139 US4982738A (en) | 1988-11-30 | 1988-11-30 | Diagnostic apnea monitor system |
US278,139 | 1988-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2004293A1 CA2004293A1 (en) | 1990-05-31 |
CA2004293C true CA2004293C (en) | 1996-04-23 |
Family
ID=23063829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002004293A Expired - Fee Related CA2004293C (en) | 1988-11-30 | 1989-11-30 | Diagnostic apnea monitor system |
Country Status (10)
Country | Link |
---|---|
US (1) | US4982738A (en) |
EP (1) | EP0371424B1 (en) |
JP (1) | JP2566655B2 (en) |
AT (1) | ATE106218T1 (en) |
AU (1) | AU623705B2 (en) |
CA (1) | CA2004293C (en) |
DD (1) | DD289198A5 (en) |
DE (1) | DE58907771D1 (en) |
ES (1) | ES2054992T3 (en) |
RU (1) | RU2096994C1 (en) |
Families Citing this family (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5522382A (en) * | 1987-06-26 | 1996-06-04 | Rescare Limited | Device and method for treating obstructed breathing having a delay/ramp feature |
US5199424A (en) * | 1987-06-26 | 1993-04-06 | Sullivan Colin E | Device for monitoring breathing during sleep and control of CPAP treatment that is patient controlled |
US5606754A (en) * | 1989-03-09 | 1997-03-04 | Ssi Medical Services, Inc. | Vibratory patient support system |
JP2794196B2 (en) * | 1989-06-20 | 1998-09-03 | チェスト株式会社 | Apnea prevention stimulator |
US5299119A (en) * | 1989-07-06 | 1994-03-29 | Qmed, Inc. | Autonomic neuropathy detection and method of analysis |
DE59106196D1 (en) * | 1990-06-29 | 1995-09-14 | Jan Ryba | Oxygen pulse respirograph. |
DE4138702A1 (en) * | 1991-03-22 | 1992-09-24 | Madaus Medizin Elektronik | METHOD AND DEVICE FOR THE DIAGNOSIS AND QUANTITATIVE ANALYSIS OF APNOE AND FOR THE SIMULTANEOUS DETERMINATION OF OTHER DISEASES |
DE4114357C2 (en) * | 1991-05-02 | 2000-07-06 | Mueller & Sebastiani Elek Gmbh | Device for automatic detection of apnea |
US5233983A (en) * | 1991-09-03 | 1993-08-10 | Medtronic, Inc. | Method and apparatus for apnea patient screening |
EP0553372B1 (en) * | 1992-01-29 | 1996-11-13 | Hewlett-Packard GmbH | Method and system for monitoring vital signs |
US5375604A (en) * | 1992-12-11 | 1994-12-27 | Siemens Medical Electronics, Inc. | Transportable modular patient monitor |
US5520176A (en) * | 1993-06-23 | 1996-05-28 | Aequitron Medical, Inc. | Iterative sleep evaluation |
EP2324765B1 (en) * | 1993-11-05 | 2015-10-07 | ResMed Limited | Control of CPAP treatment |
US6675797B1 (en) * | 1993-11-05 | 2004-01-13 | Resmed Limited | Determination of patency of the airway |
DE4338466A1 (en) * | 1993-11-11 | 1995-05-18 | Fraunhofer Ges Forschung | Method and device for the automatic detection of conspicuous breathing noises |
IL108908A (en) * | 1994-03-09 | 1996-10-31 | Speech Therapy Systems Ltd | Speech therapy system |
US5671733A (en) * | 1994-04-21 | 1997-09-30 | Snap Laboratories, L.L.C. | Method of analyzing sleep disorders |
SE508285C2 (en) * | 1994-06-07 | 1998-09-21 | Biosys Ab | Method and apparatus for assessing wakefulness and drowsiness at various stages between wakefulness and sleep in a way that is not monitored non-interfering |
US5483969A (en) * | 1994-09-21 | 1996-01-16 | Medtronic, Inc. | Method and apparatus for providing a respiratory effort waveform for the treatment of obstructive sleep apnea |
US5522862A (en) * | 1994-09-21 | 1996-06-04 | Medtronic, Inc. | Method and apparatus for treating obstructive sleep apnea |
US5540733A (en) * | 1994-09-21 | 1996-07-30 | Medtronic, Inc. | Method and apparatus for detecting and treating obstructive sleep apnea |
US5546952A (en) * | 1994-09-21 | 1996-08-20 | Medtronic, Inc. | Method and apparatus for detection of a respiratory waveform |
US5549655A (en) * | 1994-09-21 | 1996-08-27 | Medtronic, Inc. | Method and apparatus for synchronized treatment of obstructive sleep apnea |
US5485851A (en) * | 1994-09-21 | 1996-01-23 | Medtronic, Inc. | Method and apparatus for arousal detection |
US5782240A (en) * | 1994-12-22 | 1998-07-21 | Snap Laboratories, L.L.C. | Method of classifying respiratory sounds |
AUPN236595A0 (en) * | 1995-04-11 | 1995-05-11 | Rescare Limited | Monitoring of apneic arousals |
AUPN344195A0 (en) * | 1995-06-08 | 1995-07-06 | Rescare Limited | Monitoring of oro-nasal respiration |
AUPN394895A0 (en) | 1995-07-03 | 1995-07-27 | Rescare Limited | Auto-calibration of pressure transducer offset |
AUPN547895A0 (en) | 1995-09-15 | 1995-10-12 | Rescare Limited | Flow estimation and compenstion of flow-induced pressure swings cpap treatment |
JP3845736B2 (en) | 1995-09-18 | 2006-11-15 | レスメッド・リミテッド | Pressure control in CPAP treatment or assisted ventilation |
AUPN616795A0 (en) | 1995-10-23 | 1995-11-16 | Rescare Limited | Ipap duration in bilevel cpap or assisted respiration treatment |
AUPN973596A0 (en) | 1996-05-08 | 1996-05-30 | Resmed Limited | Control of delivery pressure in cpap treatment or assisted respiration |
AUPO163896A0 (en) | 1996-08-14 | 1996-09-05 | Resmed Limited | Determination of respiratory airflow |
AUPO247496A0 (en) | 1996-09-23 | 1996-10-17 | Resmed Limited | Assisted ventilation to match patient respiratory need |
US6168568B1 (en) * | 1996-10-04 | 2001-01-02 | Karmel Medical Acoustic Technologies Ltd. | Phonopneumograph system |
AUPO418696A0 (en) | 1996-12-12 | 1997-01-16 | Resmed Limited | A substance delivery apparatus |
US6093158A (en) * | 1997-05-15 | 2000-07-25 | Morris; Donald E. | Systems for modifying behavioral disorders |
AUPO742297A0 (en) | 1997-06-18 | 1997-07-10 | Resmed Limited | An apparatus for supplying breathable gas |
AUPP026997A0 (en) | 1997-11-07 | 1997-12-04 | Resmed Limited | Administration of cpap treatment pressure in presence of apnea |
US6564797B1 (en) * | 1998-09-30 | 2003-05-20 | Respironics, Inc. | Interactive pressure support system and method |
US6739335B1 (en) * | 1999-09-08 | 2004-05-25 | New York University School Of Medicine | Method and apparatus for optimizing controlled positive airway pressure using the detection of cardiogenic oscillations |
EP1276419A4 (en) * | 2000-04-20 | 2009-01-07 | Univ Monash | Method and apparatus for determining conditions of biological tissues |
US20060100666A1 (en) * | 2000-04-20 | 2006-05-11 | Pulmosonix Pty. Ltd. | Apparatus and method for lung analysis |
US20060070623A1 (en) * | 2000-04-20 | 2006-04-06 | Wilkinson Malcolm H | Method and apparatus for determining a bodily characteristic or condition |
US7708697B2 (en) * | 2000-04-20 | 2010-05-04 | Pulmosonix Pty Ltd | Method and apparatus for determining conditions of biological tissues |
US6666830B1 (en) * | 2000-08-17 | 2003-12-23 | East River Ventures, Lp | System and method for detecting the onset of an obstructive sleep apnea event |
AU2001275020A1 (en) * | 2000-09-21 | 2002-04-02 | Theradoc.Com, Inc. | Systems and methods for manipulating medical data via a decision support system |
US6561987B2 (en) | 2001-03-02 | 2003-05-13 | Opher Pail | Apparatus and methods for indicating respiratory phases to improve speech/breathing synchronization |
JP5000813B2 (en) * | 2001-06-21 | 2012-08-15 | フクダ電子株式会社 | Biological information recording apparatus and method for controlling biological information recording apparatus |
US7025729B2 (en) * | 2001-09-14 | 2006-04-11 | Biancamed Limited | Apparatus for detecting sleep apnea using electrocardiogram signals |
US7282027B2 (en) * | 2002-08-07 | 2007-10-16 | Apneos Corporation | Service center system and method as a component of a population diagnostic for sleep disorders |
US7841987B2 (en) * | 2004-03-30 | 2010-11-30 | Apneos Corporation | System and method for visualizing sleep-related information |
US20060155205A1 (en) * | 2003-11-24 | 2006-07-13 | Apneos Corp. | System and method for assessing breathing |
EP1410759A1 (en) * | 2002-10-17 | 2004-04-21 | Sibel, S.A. | Procedure for analysis of snoring and apnea and apparatus to carry out this analysis |
FR2847796B1 (en) * | 2002-11-28 | 2005-04-01 | DEVICE FOR MONITORING THE BREATH OF A PATIENT | |
US7189204B2 (en) * | 2002-12-04 | 2007-03-13 | Cardiac Pacemakers, Inc. | Sleep detection using an adjustable threshold |
CA2512843A1 (en) * | 2003-01-09 | 2004-07-29 | The Research Foundation Of State University Of New York | Method of treating functional somatic syndromes and diagnosing sleep disorders based on functional somatic syndrome symptoms |
US7662101B2 (en) * | 2003-09-18 | 2010-02-16 | Cardiac Pacemakers, Inc. | Therapy control based on cardiopulmonary status |
US7532934B2 (en) * | 2003-09-18 | 2009-05-12 | Cardiac Pacemakers, Inc. | Snoring detection system and method |
US7575553B2 (en) * | 2003-09-18 | 2009-08-18 | Cardiac Pacemakers, Inc. | Methods and systems for assessing pulmonary disease |
US8606356B2 (en) | 2003-09-18 | 2013-12-10 | Cardiac Pacemakers, Inc. | Autonomic arousal detection system and method |
US8002553B2 (en) | 2003-08-18 | 2011-08-23 | Cardiac Pacemakers, Inc. | Sleep quality data collection and evaluation |
US7610094B2 (en) * | 2003-09-18 | 2009-10-27 | Cardiac Pacemakers, Inc. | Synergistic use of medical devices for detecting medical disorders |
US8251061B2 (en) * | 2003-09-18 | 2012-08-28 | Cardiac Pacemakers, Inc. | Methods and systems for control of gas therapy |
EP1670547B1 (en) * | 2003-08-18 | 2008-11-12 | Cardiac Pacemakers, Inc. | Patient monitoring system |
US7396333B2 (en) | 2003-08-18 | 2008-07-08 | Cardiac Pacemakers, Inc. | Prediction of disordered breathing |
US7967756B2 (en) * | 2003-09-18 | 2011-06-28 | Cardiac Pacemakers, Inc. | Respiratory therapy control based on cardiac cycle |
US7887493B2 (en) | 2003-09-18 | 2011-02-15 | Cardiac Pacemakers, Inc. | Implantable device employing movement sensing for detecting sleep-related disorders |
US7668591B2 (en) * | 2003-09-18 | 2010-02-23 | Cardiac Pacemakers, Inc. | Automatic activation of medical processes |
AU2005204433B2 (en) * | 2004-01-16 | 2010-02-18 | Compumedics Medical Innovation Pty Ltd | Method and apparatus for ECG-derived sleep disordered breathing monitoring, detection and classification |
US8025063B2 (en) * | 2004-03-10 | 2011-09-27 | Apneos Corporation | System and method for treatment of upper airway disorders |
US8226569B2 (en) * | 2004-05-26 | 2012-07-24 | Sotos John G | System and method for managing sleep disorders |
US7680534B2 (en) | 2005-02-28 | 2010-03-16 | Cardiac Pacemakers, Inc. | Implantable cardiac device with dyspnea measurement |
US20060212273A1 (en) * | 2005-03-04 | 2006-09-21 | Individual Monitoring Systems.Inc. | Real-time snoring assessment apparatus and method |
US20060243280A1 (en) * | 2005-04-27 | 2006-11-02 | Caro Richard G | Method of determining lung condition indicators |
EP1879501A4 (en) | 2005-04-29 | 2009-05-20 | Oren Gavriely | Cough detector |
US20070055175A1 (en) * | 2005-05-25 | 2007-03-08 | Pulmosonix Pty Ltd | Devices and methods for tissue analysis |
US20070055115A1 (en) * | 2005-09-08 | 2007-03-08 | Jonathan Kwok | Characterization of sleep disorders using composite patient data |
US8055320B2 (en) * | 2005-10-31 | 2011-11-08 | Konica Minolta Sensing, Inc. | Vital information measuring device |
JP4617439B2 (en) * | 2005-10-31 | 2011-01-26 | コニカミノルタセンシング株式会社 | Biological information measuring device |
US20070129644A1 (en) * | 2005-12-02 | 2007-06-07 | Glenn Richards | Sleep disorder screening program |
DE102006017278A1 (en) * | 2006-04-12 | 2007-10-18 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Proof of onset of apnea |
DE102006017279A1 (en) | 2006-04-12 | 2007-10-18 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Automatic detection of hypopneas |
EP1978460B1 (en) * | 2007-04-05 | 2014-01-22 | ResMed R&D Germany GmbH | Monitoring device and method |
EP2017586A1 (en) * | 2007-07-20 | 2009-01-21 | Map-Medizintechnologie GmbH | Monitor for CPAP/Ventilator apparatus |
DE102008014652A1 (en) * | 2008-03-17 | 2009-09-24 | Robert Bosch Gmbh | Medical detection device for the detection of sleep apnea and / or sleep hypopneas |
US8424527B1 (en) * | 2008-09-05 | 2013-04-23 | Cleveland Medical Devices Inc. | Unique device for determining airway obstructions |
US8880207B2 (en) * | 2008-12-10 | 2014-11-04 | The University Of Queensland | Multi-parametric analysis of snore sounds for the community screening of sleep apnea with non-gaussianity index |
US8771204B2 (en) | 2008-12-30 | 2014-07-08 | Masimo Corporation | Acoustic sensor assembly |
US10463340B2 (en) | 2009-10-15 | 2019-11-05 | Masimo Corporation | Acoustic respiratory monitoring systems and methods |
WO2011047216A2 (en) | 2009-10-15 | 2011-04-21 | Masimo Corporation | Physiological acoustic monitoring system |
US8790268B2 (en) | 2009-10-15 | 2014-07-29 | Masimo Corporation | Bidirectional physiological information display |
US8690799B2 (en) * | 2009-10-15 | 2014-04-08 | Masimo Corporation | Acoustic respiratory monitoring sensor having multiple sensing elements |
US8579824B2 (en) * | 2009-10-30 | 2013-11-12 | Medtronic, Inc. | Method and apparatus to monitor change in inspiratory effort using intrathoracic blood pressure waveform morphology |
DE112010004682T5 (en) | 2009-12-04 | 2013-03-28 | Masimo Corporation | Calibration for multi-level physiological monitors |
US9326712B1 (en) | 2010-06-02 | 2016-05-03 | Masimo Corporation | Opticoustic sensor |
US10335060B1 (en) | 2010-06-19 | 2019-07-02 | Dp Technologies, Inc. | Method and apparatus to provide monitoring |
US8844537B1 (en) | 2010-10-13 | 2014-09-30 | Michael T. Abramson | System and method for alleviating sleep apnea |
US9192351B1 (en) | 2011-07-22 | 2015-11-24 | Masimo Corporation | Acoustic respiratory monitoring sensor with probe-off detection |
WO2013056141A1 (en) | 2011-10-13 | 2013-04-18 | Masimo Corporation | Physiological acoustic monitoring system |
US9114256B2 (en) * | 2012-01-31 | 2015-08-25 | Torytrans, S.L | Electrostimulation method and system for the treatment of sleep apnea |
US9459597B2 (en) | 2012-03-06 | 2016-10-04 | DPTechnologies, Inc. | Method and apparatus to provide an improved sleep experience by selecting an optimal next sleep state for a user |
US10791986B1 (en) | 2012-04-05 | 2020-10-06 | Dp Technologies, Inc. | Sleep sound detection system and use |
US20140051943A1 (en) | 2012-08-14 | 2014-02-20 | Good Sleep, Llc | Systems And Methods For Sleep Monitoring |
US9955937B2 (en) | 2012-09-20 | 2018-05-01 | Masimo Corporation | Acoustic patient sensor coupler |
US10828007B1 (en) | 2013-10-11 | 2020-11-10 | Masimo Corporation | Acoustic sensor with attachment portion |
CN103622697B (en) * | 2013-11-27 | 2015-12-30 | 广州医学院第一附属医院 | A kind of sleep-respiratory pathological method |
US11883188B1 (en) | 2015-03-16 | 2024-01-30 | Dp Technologies, Inc. | Sleep surface sensor based sleep analysis system |
CN105361858B (en) * | 2015-12-10 | 2018-04-03 | 广东小天才科技有限公司 | A kind of method and wearable device of blood pressure data processing |
RU167630U1 (en) * | 2016-01-20 | 2017-01-10 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный технический университет" | Device for registration and analysis of human respiratory noise |
CN105769125A (en) * | 2016-04-01 | 2016-07-20 | 深圳市前海安测信息技术有限公司 | Snoring monitoring device, application system thereof and snoring monitoring method |
EP3442401B1 (en) * | 2016-04-15 | 2020-01-08 | Koninklijke Philips N.V. | Sleep signal conditioning device and method |
WO2018089789A1 (en) | 2016-11-10 | 2018-05-17 | The Research Foundation For The State University Of New York | System, method and biomarkers for airway obstruction |
FR3064463A1 (en) | 2017-03-30 | 2018-10-05 | Fivefive | METHOD FOR DETERMINING AN ENSEMBLE OF AT LEAST ONE CARDIO-RESPIRATORY DESCRIPTOR OF AN INDIVIDUAL DURING ITS SLEEP AND CORRESPONDING SYSTEM |
US20180279947A1 (en) * | 2017-03-30 | 2018-10-04 | Sunil Kumar Ummat | Wearable device with integrated sensors |
JP7133291B2 (en) * | 2017-06-26 | 2022-09-08 | 社会医療法人春回会 | Respiratory condition determination system, respiratory condition determination program |
US11471097B1 (en) | 2018-10-15 | 2022-10-18 | Dp Technologies, Inc. | Hardware sensor system for improved sleep detection |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3572317A (en) * | 1968-10-02 | 1971-03-23 | Hoffmann La Roche | Respiratory distress monitor |
US4053951A (en) * | 1973-08-06 | 1977-10-11 | Amsco/Medical Electronics, Inc. | Data acquisition, storage and display system |
FR2377793A1 (en) * | 1977-01-25 | 1978-08-18 | Anvar | Electric breathing monitoring device - has head housing electret and counter-electrode, connected to amplifier, signal converter and indicator |
US4220142A (en) * | 1977-09-01 | 1980-09-02 | Raymond C. Rosen | Behavioral shaping device for eliminating nocturnal sounds |
DE2839331A1 (en) * | 1978-09-09 | 1980-04-03 | Ammerschlaeger Alfons Ing Grad | ECG monitoring circuit for heart current - transforms voltage into rectangular impulses which are then converted into low-pass filter for receiver head |
US4305400A (en) * | 1979-10-15 | 1981-12-15 | Squibb Vitatek Inc. | Respiration monitoring method and apparatus including cardio-vascular artifact detection |
US4333475A (en) * | 1979-12-06 | 1982-06-08 | Medical Concepts, Inc. | Ambulatory cardiac monitoring system |
US4452252A (en) * | 1981-05-26 | 1984-06-05 | Respitrace Corporation | Non-invasive method for monitoring cardiopulmonary parameters |
JPS58165823A (en) * | 1982-03-29 | 1983-09-30 | 工業技術院長 | Respiration monitor apparatus |
US4580575A (en) * | 1982-06-14 | 1986-04-08 | Aequitron Medical, Inc. | Apnea monitoring system |
AU585881B2 (en) * | 1984-07-18 | 1989-06-29 | Rita Benkendorf | Movement detection apparatus |
AU5020985A (en) * | 1984-11-20 | 1986-05-29 | Peter Robert Lambert | Breathing monitor |
US4686999A (en) * | 1985-04-10 | 1987-08-18 | Tri Fund Research Corporation | Multi-channel ventilation monitor and method |
US4777962A (en) * | 1986-05-09 | 1988-10-18 | Respitrace Corporation | Method and apparatus for distinguishing central obstructive and mixed apneas by external monitoring devices which measure rib cage and abdominal compartmental excursions during respiration |
US4827943A (en) * | 1986-09-23 | 1989-05-09 | Advanced Medical Technologies, Inc. | Portable, multi-channel, physiological data monitoring system |
JPS63189220U (en) * | 1987-05-29 | 1988-12-05 | ||
WO1988010108A1 (en) * | 1987-06-26 | 1988-12-29 | Travenol Centre For Medical Research | Device for monitoring breathing during sleep and control of cpap treatment |
-
1988
- 1988-11-30 US US07/278,139 patent/US4982738A/en not_active Expired - Fee Related
-
1989
- 1989-11-24 AU AU45519/89A patent/AU623705B2/en not_active Ceased
- 1989-11-25 AT AT89121832T patent/ATE106218T1/en not_active IP Right Cessation
- 1989-11-25 EP EP89121832A patent/EP0371424B1/en not_active Expired - Lifetime
- 1989-11-25 ES ES89121832T patent/ES2054992T3/en not_active Expired - Lifetime
- 1989-11-25 DE DE58907771T patent/DE58907771D1/en not_active Expired - Fee Related
- 1989-11-29 DD DD89335003A patent/DD289198A5/en not_active IP Right Cessation
- 1989-11-29 RU SU894742519A patent/RU2096994C1/en active
- 1989-11-30 CA CA002004293A patent/CA2004293C/en not_active Expired - Fee Related
- 1989-11-30 JP JP1309427A patent/JP2566655B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU4551989A (en) | 1990-06-07 |
EP0371424A1 (en) | 1990-06-06 |
JP2566655B2 (en) | 1996-12-25 |
CA2004293A1 (en) | 1990-05-31 |
EP0371424B1 (en) | 1994-06-01 |
ES2054992T3 (en) | 1994-08-16 |
ATE106218T1 (en) | 1994-06-15 |
AU623705B2 (en) | 1992-05-21 |
JPH02305552A (en) | 1990-12-19 |
US4982738A (en) | 1991-01-08 |
DD289198A5 (en) | 1991-04-25 |
DE58907771D1 (en) | 1994-07-07 |
RU2096994C1 (en) | 1997-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2004293C (en) | Diagnostic apnea monitor system | |
US5275159A (en) | Method and apparatus for diagnosis of sleep disorders | |
US6091973A (en) | Monitoring the occurrence of apneic and hypopneic arousals | |
US4836219A (en) | Electronic sleep monitor headgear | |
US6936011B2 (en) | Analysis of sleep apnea | |
Lerou et al. | Automated charting of physiological variables in anesthesia: a quantitative comparison of automated versus handwritten anesthesia records | |
US6064910A (en) | Respirator rate/respiration depth detector and device for monitoring respiratory activity employing same | |
Harper et al. | Machine classification of infant sleep state using cardiorespiratory measures | |
EP2265173B1 (en) | Method and system for sleep/wake condition estimation | |
Zucconi et al. | An unattended device for sleep-related breathing disorders: validation study in suspected obstructive sleep apnoea syndrome | |
JP3596117B2 (en) | Physical condition judgment support device | |
JPH01305926A (en) | Portable type electrocardiogram recording and analyzing device | |
HIDA et al. | Home sleep monitor for detecting apnea episodes by nasal flow and tracheal sound recordings | |
EP0906057A1 (en) | Apparatus for analyzing hrv signals (heart rate variation) | |
JPH0323169B2 (en) | ||
JP2023115691A (en) | Sleep disorder discrimination device and sleep disorder discrimination method | |
CA2033433C (en) | Autonomic neuropathy detection and method of analysis | |
AU743765B2 (en) | Monitoring the occurence of apneic and hypopneic arousals | |
Jaeger et al. | Instrumentation for measuring frequency of cough | |
Miller et al. | Assessment of infant-caregiver interaction using cardiac, respiratory, and behavioral monitoring: conceptual and technical issues in a new methodology | |
Mickelson | The use of sleep tests for suspected sleep disordered breathing | |
JPS63242231A (en) | Apnea measuring apparatus | |
CA1263447A (en) | Noninvasive method for measuring and monitoring intrapleural pressure in newborns | |
Gross et al. | Acoustic apnea monitoring: Preliminary results | |
Penzel | Portable recording to assess the severity of obstructive sleep apnea: A European perspective |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |